Emergency icon Important Updates

Xiangling Wang, MD

Xiangling Wang, MD
  • Watch Video
  • No ratings
  • 0 Patient Satisfaction Ratings
  • 0 Patient Comments
Department Center for Personalized Genetic Healthcare
Primary Location Cleveland Clinic Main Campus
Type of Doctor Both Adults and Children & Adolescents
Languages English
Surgeon No


Is Cleveland Clinic Part of Your Insurance?

Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.

View All Plans

About Xiangling Wang, MD

Xiangling Wang, MD, PhD, is a Staff Physician in Cleveland Clinic’s Center for Personalized Genetic Healthcare (CPGH) and Department of Kidney Medicine. She is the founding director of the combined CPGH-Glickman Urological and Kidney Institute (GUKI) renal genetics program. She sees patients on Main Campus.

Dr. Wang is one of very few double trained nephrologists and medical geneticists in the United States. She earned her MD degree from Shandong Medical University in Jinan, China, and her PhD degree from the Shanghai Jiaotong University, in Shanghai, China. She completed her medical genetics fellowship at the Mayo Clinic in Rochester, Minnesota and nephrology fellowship at the University of Texas Southwestern Medical Center in Dallas, Texas and Loma Linda University in Loma Linda, California.

Dr. Wang is an assistant professor of molecular medicine in the Case Western Reserve University Lerner College of Medicine. She has published more than 50 peer-reviewed articles, abstracts and book chapters and has presented at numerous national and international conferences. Dr. Wang has been invited as a grand rounds or guest speaker by multiple national and international academic institutes. Dr. Wang is an advisor serving north Ohio on the medical advisory board of National Kidney Foundation, an editing group member of International Society of Nephrology Academy and editorial board intern of Kidney International. She is a workgroup member for American College of Medical Genetics on practice guideline for living kidney donors genetic evaluations. Dr. Wang serves as an invited reviewer for a number of reputable journals, including Human Molecular Genetics, and as an abstracts reviewer for national and international conferences, including American Society of Nephrology Kidney Week.

Education & Professional Highlights

Education & Professional Highlights


Education & Fellowships

Fellowship - Loma Linda University
Loma Linda, CA

Fellowship - University of Texas Southwestern Medical Center
Dallas, TX

Residency - Mayo Clinic
Medical Genetics
Rochester, MN

Graduate School - Shanghai Jiao Tong University

Residency - Shandong University Medical School
Internal Medicine
Jinan Shandong, China

Medical Education - Shandong University Medical School
Jinan Shandong, China


  • Internal Medicine - Nephrology
  • Medical Genetics and Genomics - Clinical Genetics and Genomics
  • Internal Medicine
Research & Publications

Research & Publications

See publications for Xiangling Wang, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 4/29/2024, Dr. Wang has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Back to Top